Save lives with early cancer detection
Cancer is the #2 leading cause of death now and is estimated to be the #1 cause of death globally by the mid-2020s. Multi-cancer early detection could lead to a 40% reduction in cancer deaths.
Multi-cancer Early Detection
miRoncol can detect 12 cancer types and will expand to more.
miRoncol test is based on a simple blood draw.
miRoncol test demonstrates superior performance with high specificity and sensitivity.
miRoncol brings an affordable solution that can be done through RT-PCR which is mature and cheaper.
Scientific Proven Performance
Types of Cancer are supported and more are coming
Specificity, i.e. only <1% of positive results have no cancer.
Sensitivity, i.e. ~85% of actual cancer cases are detected.
blood samples for initial validation with statistical significance.